In the epicenter of the Lushan M S 7.0 earthquake there are several imbricate active reverse faults lying from northwest to southeast, namely the Gengda-Longdong, Yanjing-Wulong, Shuangshi-Dachuan and Dayi faults. Emergency field investigations have indicated that no apparent earthquake surface rupture zones were located along these active faults or their adjacent areas. Only brittle compressive ruptures in the cement-covered pavements can be seen in Shuangshi, Taiping, Longxing and Longmen Townships, and these ruptures show that a local crustal shortening occurred in the region during the earthquake. Combining spatial distribution of the relocated aftershocks and focal mechanism solutions, it is inferred that the Lushan earthquake is classified as a typical blind reverse-fault earthquake, and it is advised that the relevant departments should pay great attention to other historically un-ruptured segments along the Longmenshan thrust belt and throughout its adjacent areas.Lushan earthquake, earthquake surface rupture zone, blind reverse-fault earthquake, Longmenshan thrust belt, Qinghai-Tibetan Plateau
Citation:Xu X W, Wen X Z, Han Z J, et al. Lushan M S 7.0 earthquake: A blind reserve-fault event.
Use policyThe full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that:• a full bibliographic reference is made to the original source • a link is made to the metadata record in DRO • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders.Please consult the full DRO policy for further details. the three fault surfaces on the Huoshan piedmont fault, we identify three earthquake events.
27The coseismic vertical displacement of the characteristic earthquake on the Huoshan piedmont 28 fault is estimated to be 3-4 m, the average width of these fault surface bands. Gaps with a width
Objective: To compare the efficacy of autologous serum (AS) eye drops and artificial tears (AT) in dry eye disease (DED). Methods: Five databases (PubMed, Science Direct, the Cochrane Library, the Chinese National Knowledge Infrastructure, and the Wanfang Database) were searched for randomized controlled trials (RCTs). Efficacy was evaluated in terms of the Ocular Surface Disease Index (OSDI), Schirmer I test, tear break-up time (TBUT), and fluorescein and rose bengal staining of ocular surface. The estimated effects of AS or AT were expressed as a proportion with the 95% confidence interval and plotted on a forest plot. Results: Seven RCTs with 267 subjects were included in the meta-analysis. For most of the studies, subjects' age was around 50 years old, and the mostly treatment duration was within 8 weeks. The followup results showed that the OSDI after AS treatment was lower than that after the AT treatment: the mean difference (MD) was-10.75 (95% CI,-18.12;-3.39) points. There was no difference on the Schirmer I test after treatment between the two groups: the MD was 1.68 (95% CI,-0.65; 4.00) mm. The TBUT of the AS group was longer than that of the AT group, with an MD of 4.53 (95% CI, 2.02; 7.05) s. There was no statistically significant difference on fluorescein staining score of the ocular surface between the AS group and the AT group, the MD was-2.53 (95% CI,-6.08; 1.03) points. The rose bengal staining score of the AS group was slightly lower than that of the AT group after treatment: the MD was-0.78 (95% CI,-1.34;-0.22) points. Conclusion: AS could be an effective treatment for DED, improving OSDI, TBUT, and rose bengal staining score. Further RCTs with large samples and longterm follow-up are still needed to determine the exact role of AS in the management of DED.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.